기니픽을 이용한 Sweet Bee Venom의 항원성 평가
Experimental study of antigenicity test of Sweet Bee Venom in Guinea Pigs
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives: This study was performed to examine the antigenic potential of pure melittin (Sweet Bee Venom - SBV) extracted from the bee venom by utilizing protein isolation method of gel filtration. Methods: All experiments were conducted at Biotoxtech (Chungwon, Korea), authorized a non-clinical studies institution, under the regulations of Good Laboratory Practice (GLP). Antigenic potential of SBV was examined by active systemic anaphylaxis (ASA) and passive cutaneous anaphylaxis (PCA) in guinea pigs. SBV was subcutaneously administered at 0.07 and 0.28㎎/㎏and also as a suspension with adjuvant (Freund's complete adjuvant: FCA). Ovalbumin (OVA) as a suspension with adjuvant was used to induce positive control response (5㎎/㎖- FCA). Results:1. In the ASA test, experimental groups showed some symptoms of anaphylaxis like piloerection,hyperpnea and staggering gait. 2. In the PCA test, low dosage group did not show any antibody responses, whereas high dosage group showed positive responses. 3. In the weight measurement and clinical observation, experimental groups didn't show any significant changes compared with control group. 4. In the autopsy of body, the abnormalities of lung were detected in the corpse. This means that the cause of death may induced anaphylactic shock. Conclusions: Above findings suggested that SBV had antigenic potential in guinea pig. Further studies on the subject should be conducted to yield more concrete evidences.
Abstract
Objectives: This study was performed to examine the antigenic potential of pure melittin (Sweet Bee Venom - SBV) extracted from the bee venom by utilizing protein isolation method of gel filtration. Methods: All experiments were conducted at Biotoxtech (Chungwon, Korea), authorized a non-clinical studies institution, under the regulations of Good Laboratory Practice (GLP). Antigenic potential of SBV was examined by active systemic anaphylaxis (ASA) and passive cutaneous anaphylaxis (PCA) in guinea pigs. SBV was subcutaneously administered at 0.07 and 0.28㎎/㎏and also as a suspension with adjuvant (Freund's complete adjuvant: FCA). Ovalbumin (OVA) as a suspension with adjuvant was used to induce positive control response (5㎎/㎖- FCA). Results:1. In the ASA test, experimental groups showed some symptoms of anaphylaxis like piloerection,hyperpnea and staggering gait. 2. In the PCA test, low dosage group did not show any antibody responses, whereas high dosage group showed positive responses. 3. In the weight measurement and clinical observation, experimental groups didn't show any significant changes compared with control group. 4. In the autopsy of body, the abnormalities of lung were detected in the corpse. This means that the cause of death may induced anaphylactic shock. Conclusions: Above findings suggested that SBV had antigenic potential in guinea pig. Further studies on the subject should be conducted to yield more concrete evidences.
참고문헌 (32)
- Academic committee of Korean Pharmacopuncture Institute, "Pharmacopuncturology", pp.167~199 (2008), Elsevier Korea
- Kwon KR, "An Experimental Study with Bee Venom Therapy on Anti-inflammatory and Analgesic Effects", The Journal of Korean Acupuncture & Moxibustion Society, 15(2), pp.97~103 (1998)
- Ko HK, "Experimental Studies on the Effect of Bee Venom Theraphy on the Analgesic, Antipyretic and Anti-inflammatory Action", Korean Journal of Oriental Medicine, 13(1), pp.283~292 (1992)
- 이성노, "蜂藥鍼治療의 退行性膝關節炎에 대한 臨床的 考察", 대한침구의학회지, 20(5), pp.6~ (2003), 대한침구의학회
- Wang WH, "Clincal Investigation Compared with the Effects of the Bee Venom - Acupuncture on Knee Joint with Osteoarthritis", The Journal of Korean Acupuncture & Moxibustion Society, 18(3), pp.35~47 (2001)
- Hwang YJ, "Clinical Study of Anaphylaxis on Bee-Venom Acupuncture", The Journal of Korean Acupuncture & Moxibustion Society, 17(4), pp.149~159 (2000)
- 윤현민, "봉약침요법으로 발생한 Anaphylaxis에 대한 임상보고", 대한침구의학회지, 22(4), pp.179~188 (2005), 대한침구의학회
- Robert L, "Allergy, Hypersensitivity, Anaphylaxis. Emergency Medicine", pp.2759~2766 (1998), Mosby Year Book
- 최영권, "Gel filtration chromatography와 propionic acid", urea polyacrylamide gel electrophoresis를 이용한 봉독 성분의 분리, 2006, pp.9(2), 105~111[DOI]
- 권기록, "Sweet BV의 성분분석과 항체역가 및 allergy 반응에 대한 임상적 연구", 대한약침학회지, 9(2), pp.79~86 (2006), 대한약침학회
- 이진선, "봉약침(Bee Venom)과 Sweet Bee Venom의 Allergy 반응에 대한 비교연구", 대한약침학회지, 9(3), pp.61~77 (2006), 대한약침학회
- 임청산, "Sweet BV가 복부 비만에 미치는 영향", 대한약침학회지, 11(2), pp.33~40 (2008), 대한약침학회
- 유화승, "암성통증에 대한 SBVP 효과-무작위대조시험, 이중맹검", 대한약침학회지, 11(1), pp.21~29 (2008), 대한약침학회
- 김성철, "동일 농도(0.1㎎", ㎖)의 Sweet Bee Venom과 봉약침의 퇴행성 슬관절염에 대한 임상연구, 2008, pp.11(1), 31~40[DOI]
- 송범룡, "교통사고로 인한 편타 손상 환자에 대한 Sweet Bee Venom 약침의 임상적 효과", 대한약침학회지, 10(3), pp.77~83 (2007), 대한약침학회
- 이태호, "요각통 환자에 대한 Bee Venom과 sweet Bee Venom의 효능 비교 연구", 대한약침학회지, 10(3), pp.85~89 (2007), 대한약침학회
- 권기록, "Sweet BV 시술 후 발생한 과민반응 환자의 증례보고", 대한약침학회지, 12(2), pp.85~90 (2009), 대한약침학회
- 김영진, "Sweet BV의 rat를 이용한 단회 근육시술 독성시험", 대한약침학회지, 12(4), pp.5~32 (2009), 대한약침학회
- 윤휘철, "Sweet Bee Venom의 비글견을 이용한 단회근육시술 독성시험", 대한약침학회지, 13(4), pp.43~62 (2010), 대한약침학회
- 임청산, "Sweet BV가 비글견의 심혈관계에 미치는 영향", 대한약침학회지, 13(3), pp.15~46 (2010), 대한약침학회
- 박재석, "Sweet Bee Venom의 비글견을 이용한 4주 반복 근육시술 독성시험", 대한약침학회지, 13(4), pp.5~42 (2010), 대한약침학회
- 식품의약품안전청, "식품의약품안전청고시 제2008-56호", ~
- 식품의약품안전청, "식품의약품안전청고시 제2005-79호", ~
- Karol MH, "Antibody-mediated hypersensitivity", pp.305~322 (1997), Pergamon Press
- Huh IH, "Toxicology", pp.9~10 (1993), Shinil Books
- Kim YG, "Toxicology", pp.15~18 (1984), DongHwa Technology Publishing Co
- Barbara, "Chemistry and Pharmacology of Honey Bee venom", pp.329~402 (1986), Academic Press
- Renata MS, "Structural and functional behavior of biologically active monomeric melittin", J Molecular Graphics and Modelling, 25, pp.767~772 (2007)
- Park HJ, "JNK pathway is involved on the inhibition of inflammatory target gene expression and NF-κB activation by melittin", J. Inflammation, 5(7), pp.1~13 (2008)
- Lind DS, "nuclear factor-κB is upregulated in colorectal cancer", Surgery, 130, pp.363~369 (2001)
- Aranha MM, "NF-κB and apotosis in colorectal tumorigenesis", Eur J Clin Invest, 37, pp.416~424 (2007)
- Mota I, "Homologous and hetrogous passive cutaneous anaphylactic activity of mouse antisera during the course of immunization", Life Sci, 8, pp.813~820 (1969)
